Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Hemostatic Powder (Endo-clotTM) in Prevention of Bleeding Within High Risk Patients After ESD

NCT02625792 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT02625792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02625792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Hemostatic Powder (Endo-clotTM) in Prevention of Bleeding Within High Risk Patients After ESD
Lead sponsor
Yonsei University
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2015
Completion date
October 31, 2016
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iatrogenic ulcer after esd